I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Leave site
Roche and Genentech at

ISPOR Europe 2026

We will be contributing to topics related to
-
03:00 PM
Duration 120mins Vienna, Austria
Cost-Effectiveness of Obinutuzumab for the Treatment of Active Lupus Nephritis in the United Kingdom
Carolina Heuser Sanmartin, Lewis Ralph
Duration 180mins Vienna, Austria
Quantifying the "Invisible" Burden: Estimating Undiagnosed Cardio-Renal-Metabolic Conditions Using Linked EMR-Claims Data
Titilope Akinola, Charlotta Fruechtenicht, Christina Lorenz, Melina Arnold
Duration 60mins Vienna, Austria
An 8-Point Worsening And A 10-Point Improvement On The Multiple-Sclerosis Impact Scale 29-Item (MSIS-29) V2 Are Clinically Meaningful
Tammy McIver, Ying-Fang Chen, Tracy Holt, Jeremy Hobart
09:30 AM
Duration 150mins Vienna, Austria
Burden of Severe Chronic Obstructive Pulmonary Disease Exacerbations in England: The COpd seVere ExaceRbationS (COVERS) Real-World Evidence Study
Bethany Levick, Parul Dayal, Luca Le Treust,Shea O’Connell,Jennifer K Quint, Nick Jovanoski, Johannes Ammann, Ajay Patel
Duration 180mins Vienna, Austria
Characterizing People with Untreated Multiple Sclerosis in Real-World Evidence: Insights from Literature and the German NeuroTransData Registry (2018–2024)
Carmen G. Berardo, Stefan Braune, Yanic Heer, Martin Traber, Ana Ferro, Arnfin Bergmann, Katya Glactionova
03:00 PM
Duration 120mins Vienna, Austria
Deciphering the Economic Burden of Thyroid Eye Disease: A Retrospective Claims Analysis
Stella Ko, David Tabano, Zhiyu Xia, Rongrong Wang, Ayesha Ahmed, Sera-Leigh Ghouralal, Noha Keshk, Giulio Barteselli
08:00 AM
Duration 150mins Vienna, Austria
Healthcare Resource Use of Chronic Obstructive Pulmonary Disease Exacerbations: A Retrospective Analysis of German Claims Data
Kai-Michael Beeh, Kathrin Kahnert, Nils Picker, Sabine Bartel, Nick Jovanoski, Katerina Samara, Parul Dayal, Johannes Ammann
Duration 150mins Vienna, Austria
Characterising Patients With Uncontrolled Chronic Obstructive Pulmonary Disease in the US: A Latent Class Analysis Incorporating Clinical, Socioeconomic and Demographic Factors
Karina Raimundo, Achal Patel, Arpamas Seetasith, Cindy Burg, Valerie Crowell, Aaron Levine
Duration 60mins Vienna, Austria
Development of the Retinal Vascular Disease Questionnaire to Assess Visual Symptoms, Vision-Related Impacts, and Treatment Satisfaction in DR, DME, and nAMD
Salena Preciado, Finger RP, Moniz L, Owsley C, Paudel N, Mayhew M, O’Brien N, Renwick A, Barclay M, Williams-Hall R, Flynn J, Sully K, Braid J, Sim D, Haskova Z, Ackermann J
Coming soon